Credit: Shutterstock photoCorindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, raised $42 million on Thursday night by offering 11 million shares at $3.80.
The company's stock had been trading on the OTCQB under the symbol CVRS at $4.25 when Corindus set terms on Tuesday for the public offering. Its shares had fallen to $4.00 on Friday on low volume.
Primary shareholders include HealthCor Partners Management (38% post-IPO stake), Koninklijke Philips (18%), Robert Smith (9%), 20/20 Capital (6%) and CEO David Handler (3%).
Corindus Vascular Robotics listed its shares on the NYSE MKT under the symbol CVRS. Cowen & Company and Stifel acted as lead managers on the deal.
The article In-stent precision: Corindus Vascular Robotics prices public offering at $3.80 originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
